Cargando…

A single dose of recombinant VSV-RABV(G) vaccine provides full protection against RABV challenge

• A replication-competent recombinant VSV with RABV-G protein replacement was generated. • Single dose of VSV-RABV(G) immunization induces potent anti-RABV(G) immune response, including viral neutralizing antibodies. • Mice intranasally immunized with single dose of VSV-RABV(G) were 100% protected u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Minglong, Wang, Zongmei, Wu, Chuanjian, Xiong, Sidong, Zhao, Ling, Dong, Chunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wuhan Institute of Virology, Chinese Academy of Sciences 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243626/ https://www.ncbi.nlm.nih.gov/pubmed/35618603 http://dx.doi.org/10.1016/j.virs.2022.02.008

Ejemplares similares

Phenotypic Consequence of Rearranging the N Gene of RABV HEP-Flury
por: Mei, Mingzhu, et al.
Publicado: (2019)

Genetic and evolutionary characterization of RABVs from China using the phosphoprotein gene
por: Wang, Lihua, et al.
Publicado: (2013)

Host Desmin Interacts with RABV Matrix Protein and Facilitates Virus Propagation
por: Zhang, Wen, et al.
Publicado: (2023)

Phenotypic Consequences In vivo and In vitro of Rearranging the P Gene of RABV HEP-Flury
por: Mei, Mingzhu, et al.
Publicado: (2017)

Comparison of Pan-Lyssavirus RT-PCRs and Development of an Improved Protocol for Surveillance of Non-RABV Lyssaviruses
por: Drzewnioková, Petra, et al.
Publicado: (2023)

Autophagy is highly targeted among host comparative proteomes during infection with different virulent RABV strains
por: Li, Ling, et al.
Publicado: (2017)

An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
por: Zhang, Haili, et al.
Publicado: (2022)

Zero Endemic Cases of Wildlife Rabies (Classical Rabies Virus, RABV) in the European Union by 2020: An Achievable Goal
por: Robardet, Emmanuelle, et al.
Publicado: (2019)

Recombinant Human Adenovirus Type 5 Co-expressing RABV G and SFTSV Gn Induces Protective Immunity Against Rabies Virus and Severe Fever With Thrombocytopenia Syndrome Virus in Mice
por: Zhao, Zhongxin, et al.
Publicado: (2020)

Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7
por: Embregts, Carmen W. E., et al.
Publicado: (2021)

Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses
por: Plummer, Joseph R., et al.
Publicado: (2019)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
por: Yahalom-Ronen, Yfat, et al.
Publicado: (2020)

Single dose rVSVΔG-JUNVGP vaccine protects guinea pigs against lethal Junin virus challenge
por: Sorvillo, Teresa E., et al.
Publicado: (2021)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy
por: Liang, Minglong, et al.
Publicado: (2021)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

A VSV-based Zika virus vaccine protects mice from lethal challenge
por: Emanuel, Jackson, et al.
Publicado: (2018)

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation
por: Marzi, Andrea, et al.
Publicado: (2019)

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates
por: Bhatia, Bharti, et al.
Publicado: (2023)

The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs
por: Cao, Wenguang, et al.
Publicado: (2023)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles
por: Skinner, Amy M., et al.
Publicado: (2013)

Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
por: Marzi, Andrea, et al.
Publicado: (2021)

Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography
por: Lerer, Elad, et al.
Publicado: (2021)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
por: Montagna, Claudia, et al.
Publicado: (2018)

Insights from the Infection Cycle of VSV-ΔG-Spike Virus
por: Milrot, Elad, et al.
Publicado: (2022)

Optimization of single dose VSV-based COVID-19 vaccination in hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge
por: Yin, Liang, et al.
Publicado: (2017)

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
por: Vijver, Saskia V., et al.
Publicado: (2023)

Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose
por: Zhang, Ming, et al.
Publicado: (2017)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection
por: Fletcher, Paige, et al.
Publicado: (2023)

Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization
por: Shan, Dan, et al.
Publicado: (2022)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus
por: Dong, Fangfang, et al.
Publicado: (2019)

Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine
por: O'Donnell, Kyle L., et al.
Publicado: (2023)

A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
por: Ao, Zhujun, et al.
Publicado: (2022)

Optimizing expression of functional HIV envelopes in rVSV-ΔG vaccine vectors
por: Wright, KJ, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gkbc187s62fntbubsl9okh756u